project id: TCGA-LUAD; case submitter id: TCGA-MP-A4TJ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; rna integrity number: 8.3; age at index: 62; days to birth: -22875; days to death: 339; ethnicity: not reported; gender: female; race: not reported; vital status: Dead; year of birth: 1944; year of death: 2006; age at diagnosis: 22875; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8490/3; primary diagnosis: Signet ring cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 2204; days to sample procurement: 0; initial weight: 270.0; portion submitter id: TCGA-MP-A4TJ-01A-51; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 10.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;